Biomarkers of cardiovascular disease in patients with Type 2 diabetes

Abstract

Patients with Type 2 diabetes have an increased risk of cardiovascular disease. However, there exists a considerable heterogeneity in cardiovascular risk in this patient population. A heterogeneity, which may escape the predictive capability of established clinical risk scores. In this context, cardiovascular biomarkers are of significant interest as potential clinical tools to guide risk stratification of patients. Studies have identified N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin T of particular potential in patients with Type 2 diabetes.

Bidragets oversatte titelBiomarkers of cardiovascular disease in patients with Type 2 diabetes
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind181
Udgave nummer8
ISSN0041-5782
StatusUdgivet - 18 feb. 2019

Emneord

  • Biomarkers/analysis
  • Cardiovascular Diseases/complications
  • Diabetes Mellitus, Type 2/complications
  • Humans
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Troponin T

Fingeraftryk

Dyk ned i forskningsemnerne om 'Biomarkers of cardiovascular disease in patients with Type 2 diabetes'. Sammen danner de et unikt fingeraftryk.

Citationsformater